Anacor Pharmaceuticals, Inc. to Present Preclinical Data on Orally Active PDE4 Inhibitor at the 8th Cytokines and Inflammation Conference

Bookmark and Share

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals announced today that it will present a poster and oral presentation on a novel systemic anti-inflammatory candidate, AN6415, at the upcoming 8th Cytokines and Inflammation Conference, taking place January 28-29, 2010 in La Jolla, California.
MORE ON THIS TOPIC